GENEVA, Switzerland – May 22, 2018 – Research to develop life-saving products, including new vaccines and other products to protect against deadly drug-resistant bacterial infections, got a significant boost today.
The UK Government’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) and the Bill & Melinda Gates Foundation (BMGF) have joined the CARB-X partnership to support scientific research around the world to develop new vaccines, preventatives, and other products against drug-resistant bacterial infections, particularly among vulnerable populations in low- and middle-income countries.
